DRI-ecstasy plus mdma/MDA reagent

Ended Awarded

Contract number
N6854623F3015
Awardee
Awarding agency
Obligated
$12,039

Award facts

Contract value 100% obligated
$12,039.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fremont, CA 94538, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA reagent. Microgenics, a division of Thermo Electron Corporation, will deliver the requested drug identification and screening reagents to the agency's location in Fremont, California by April 26, 2023. The contract has no set-aside designation. As a provider of clinical diagnostic solutions, Microgenics is well positioned to support the Bureau of Medicine and Surgery's efforts to test for illegal and controlled substances.

Quick answers

Who was awarded contract N6854623F3015?

N6854623F3015 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on April 17, 2023.

How much is contract N6854623F3015 worth?

The government has obligated $12,039 on N6854623F3015.

Is contract N6854623F3015 an order under another contract?

Yes. N6854623F3015 is a delivery order under N6264519D5003, an indefinite delivery contract.

Was contract N6854623F3015 competed?

The extent of competition for N6854623F3015 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award